Bonraybio Co (TPE:6955) Total Operating Expense: NT$138.6 Mil (TTM As of Dec. 2025)


TPE:6955 Bonraybio Co Ltd TPE:6955
65 GF Score
Price NT$120.00
GF Value NT$184.74
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Bonraybio Co Total Operating Expense?

Bonraybio Co TPE:6955 -0.41% 65 Total Operating Expense is NT$138.6 Mil as of Dec. 2025. GuruFocus rates TPE:6955 with a GF Score™ of 65/100 and a GF Value™ of NT$184.74 (Possible Value Trap). The stock has 4 warning signs investors should review.

Bonraybio Co's Total Operating Expense for the three months ended in Dec. 2025 was NT$36.9 Mil. Bonraybio Co's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$138.6 Mil.

Bonraybio Co Total Operating Expense Related Terms

Bonraybio Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Bonraybio Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonraybio Co Total Operating Expense Chart

Bonraybio Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 78.08 87.23 98.45 114.01 138.57

Bonraybio Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.72 32.61 35.18 33.92 36.87
TPE:6955
65GF Score
Bonraybio Co Ltd TPE:6955
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonraybio Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$138.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of NT$138.6 Mil mean?
Bonraybio Co (TPE:6955) has a Total Operating Expense of NT$138.6 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Bonraybio Co and its competitors.
Is Bonraybio Co's Total Operating Expense too high?
Bonraybio Co's current Total Operating Expense is NT$138.6 Mil. Overall, Bonraybio Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonraybio Co's Total Operating Expense compare to ABT and SYK?
Bonraybio Co's Total Operating Expense of NT$138.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Bonraybio Co and its competitors. Bonraybio Co's current Total Operating Expense is NT$138.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonraybio Co stock overvalued right now?
Based on GuruFocus' analysis, Bonraybio Co (TPE:6955) is currently considered Possible Value Trap. The stock's GF Value™ is NT$184.74, compared to a current price of NT$120.00 — trading 35% below its estimated fair value. The current Total Operating Expense is NT$138.6 Mil. Bonraybio Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Bonraybio Co (TPE:6955), the current Total Operating Expense is NT$138.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonraybio Co (TPE:6955) Overvalued in 2026?

Based on GuruFocus' analysis, Bonraybio Co stock appears to be undervalued. The current stock price of NT$120.00 is trading 35% below its estimated GF Value™ of NT$184.74. GuruFocus considers Bonraybio Co to be Possible Value Trap.

Key valuation signals for TPE:6955:

  • Total Operating Expense: NT$138.6 Mil
  • GF Value™: NT$184.74 vs. price of NT$120.00 (35% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the TPE:6955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bonraybio Co Business Description

Address No. 118, Gongye 9th Road, 4th Floor, Dali District, Taichung City, TWN
Bonraybio Co Ltd engages in research, development, and manufacturing of vitro diagnostic devices. The firm produces semen quality analyzers and Semen Analysis Systems for the clinic.
65GF Score

Get the complete analysis for TPE:6955

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$120.00
Price
NT$184.74
GF Value